Waitlisted and Transplant Patient Perspectives on Expanding Access to Deceased-Donor Kidney Transplant: A Qualitative

Canute Rosaasen1, Nicola Rosaasen2, Rahul Mainra3

  • 1Johnson Shoyama Graduate School of Public Policy, University of Saskatchewan, Saskatoon, Canada.

Abstract

Insights

Patients are willing to accept marginal kidneys for transplant if their autonomy is respected and they receive clear, trustworthy information. This research aims to improve kidney transplant access by understanding patient perspectives on using less-than-ideal organs.

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Patient-Centered Care

Background:

  • Many expanded donor criteria kidneys are discarded annually.
  • Patients awaiting kidney transplants face significant morbidity and mortality.
  • Patient perceptions of using marginal kidneys are largely unexplored.

Purpose of the Study:

  • To explore patient perspectives on accepting marginal kidney allografts.
  • To understand patient needs for information and autonomy in decision-making.

Main Methods:

  • Qualitative descriptive study involving semi-structured interviews.
  • 15 interviews conducted with pre- and post-transplant patients in Canada.
  • Thematic analysis used to identify key themes.

Main Results:

  • Four themes emerged: patient awareness, desire for information, freedom from dialysis, and trust.
  • Transparency, clarity, standardization, and autonomy are crucial for patient education.
  • Most pre-transplant patients would accept a marginal kidney if it offered 3-5 years off dialysis.

Conclusions:

  • Patients are willing to accept marginal kidneys when autonomy, clear information, and physician trust are prioritized.
  • Findings will inform a national registry to expand deceased-donor kidney transplant access.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
66
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
81
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
89
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
531